Skip to content

Clinical trials

Neurodegenerative Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Country / region: France Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20083
20092
20101
20112
20121
20133
20142
20151
20163
20173
20184
20195
20204
20214
20227
202310
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting8
Terminated8
Active, not recruiting7
Not yet recruiting1
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GenSight Biologics5
AbbVie4
Assistance Publique - Hôpitaux de Paris4
Central Hospital, Nancy, France4
Centre Hospitalier Universitaire de Nice3
Novartis Pharmaceuticals3
Affiris AG2
AstraZeneca2
Centre Hospitalier Universitaire, Amiens2
LYSOGENE2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases67
Alzheimer Disease22
Nervous System Diseases22
Dementia19
Brain Diseases17
Central Nervous System Diseases16
Genetic Diseases, Inborn10
Neurocognitive Disorders10
Cognitive Dysfunction9
Mental Disorders8

Trials

Showing 26 to 50 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.